QUILLIVANTXR
Dead / Abandoned — Abandoned — failure to respond (as of 11 May 2014)
What this means for you
This application is over — abandoned 11 Apr 2014. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 85704153
- Mark type
- Stylized text
- Filed
- 15 Aug 2012
- Published for opposition
- 22 Jan 2013
- Abandoned
- 11 Apr 2014
- Attorney of record
- Richard A. Friedman
Goods and services
- Class 005 — Pharmaceuticals: Oral liquid suspension pharmaceutical preparations for the extended relief of central nervous system diseases and disorders and for the treatment of attention deficit hyperactivity disorder; methylphenidate hydrochloride in oral suspension liquid form for the extended relief of central nervous system diseases and disorders and for the treatment of attention deficit hyperactivity disorder
Owner
- NextWave Pharmaceuticals, Inc., Cupertino, CA, US
- NextWave Pharmaceuticals, Inc., Cupertino, CA, US
Prosecution history
- 12 May 2014 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 11 May 2014 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 11 Oct 2013 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Oct 2013 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 10 Oct 2013 — NON-FINAL ACTION E-MAILED
- 10 Oct 2013 — SU - NON-FINAL ACTION - WRITTEN
- 10 Oct 2013 — STATEMENT OF USE PROCESSING COMPLETE
- 29 Aug 2013 — USE AMENDMENT FILED
- 10 Oct 2013 — SOU EXTENSION 1 GRANTED
- 29 Aug 2013 — SOU EXTENSION 1 FILED
- 03 Oct 2013 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 29 Aug 2013 — SOU TEAS EXTENSION RECEIVED
- 29 Aug 2013 — TEAS STATEMENT OF USE RECEIVED
- 19 Mar 2013 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 22 Jan 2013 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED